THE Board of Investments (BOI) on Monday said it has cleared the application of Lloyd Laboratories Inc. to be the domestic producer of Molnupiravir, an oral therapy for Covid-19 patients.
In a statement, BOI said the P24-million project was approved for complying with the qualification requirements for "All Qualified Activities Relating to the Fight against the Covid-19 Pandemic — Essential Goods" Listing of the 2020 IPP as the transitional Strategic Investment Priorities Plan (SIPP) under the Corporate Recovery and Tax Incentives for Enterprises Act (Create) Law.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.